GlaxoSmithKline News and Research

RSS

Bill Gates puts his money where his mouth is again

Once again Microsoft founder Bill Gates is putting his money where his mouth is and the world's poorest women will benefit.

6 Jun 2006

"Smart bomb" cancer therapy combo effective

Experts have more good news on the breast cancer front; they say they by using a combination of therapies it may be possible to extend the lives of thousands of women with advanced breast cancer.

4 Jun 2006

New tool identifies those at risk of bipolar disorder

According to a new study researchers have identified five predictors for bipolar disorder risk in patients who have been unsuccessfully treated with antidepressants.

23 May 2006

FDA gives tentative approval to new generic AIDS drug

The Food and Drug Administration (FDA) today announced the tentative approval of generic abacavir sulfate tablets manufactured by Aurobindo Pharma LTD. of Hyderabad, India.

18 May 2006

FDA warns of suicide risk with Paxil

The Food and Drug Administration (FDA) in the U.S., has notified healthcare professionals in the States and the UK that the antidepressant Paxil produced by GlaxoSmithKline (GSK), appears to raise the risk of suicide in young adults.

15 May 2006

U.S. watchdog says Xenical should be withdrawn

A consumer watchdog group in the U.S., Public Citizen, has petitioned the U.S. Food and Drug Administration (FDA) to withdraw the prescription diet drug Xenical (orlistat) from the market; the group also want the FDA to refuse approval for the weight-loss pill to be made widely available over the counter.

11 Apr 2006

High levels of HDL cholesterol more important than low levels of LDL in protecting against heart attack

The researchers looked at the history of heart disease, age, sex, race, weight and other heart disease risk factors in almost 7,000 patients. The patients were predominately inner city residents and included a large number of African Americans, women, smokers and overweight people.

4 Apr 2006

GlaxoSmithKline announces start of clinical trials to test two pandemic vaccines against the H5N1

GlaxoSmithKline has announced the start of an international clinical trial program to test two pandemic vaccines against the H5N1 strain of the avian influenza virus in humans. This dual approach reflects the company's commitment to provide health authorities with concrete options to face the threat of a pandemic.

30 Mar 2006

Clear evidence that elephantiasis can be eliminated

Clear evidence that Lymphatic Filariasis (LF, commonly known as elephantiasis) can be eliminated is reported in The Lancet. LF is one of the world's most disfiguring and disabling parasitic diseases, and the target of one of the largest global public health programs using mass drug administration (MDA).

28 Mar 2006

Asthma drug approved for children age four up

The U.S. Food and Drug Administration (FDA) has given approval for the use of the asthma drug Flovent HFA in children four to eleven years of age.

26 Mar 2006

U.S. buys more Relenza and Tamiflu for future influenza pandemics

The United States Department of Health and Human Services has announced additional purchases of antiviral drugs that could be used in the event of a potential influenza pandemic.

23 Mar 2006

GlaxoSmithKline receives NDA for Coreg CR

GlaxoSmithKline has announced that the new drug application (NDA) for Coreg CR has been accepted for review by the U.S. Food and Drug Administration (FDA).

17 Mar 2006

New hepatitis drug much more effective

Chronic infection with the hepatitis B virus (HBV) is responsible for an enormous burden of disease throughout the world, including up to half of all cases of cirrhosis, end-stage liver disease, and hepatocellular carcinoma, a cancer of the liver.

9 Mar 2006

Acute stress boosts flu shot response in women

Women who participated in short bouts of physical or mental activity before receiving a flu shot produced more antibodies than other women, according to the first study of this effect in humans.

7 Mar 2006

Cervical cancer vaccines in development

Two preventative vaccines, Gardasil (Merck) and Cervarix (GlaxoSmithKline) that work against the Human Papilloma virus (HPV) - a sexually transmitted infection and the primary cause of cervical cancer - are gaining favorable attention.

27 Feb 2006

Bristol-Myers Squibb agrees to record securities litigation settlement with sweeping drug disclosure requirements announces Labaton Sucharow

After prosecuting the securities litigation claims against Bristol-Myers Squibb Co. (BMS) for over five years, Labaton Sucharow, Lead Counsel representing the class and Lead Plaintiff, the LongView Collective Investment Fund of the Amalgamated Bank, reached an agreement in principle to settle the claims for $185 million in addition to meaningful corporate governance reforms that will affect future consumers and investors alike.

23 Jan 2006

Chemical warfare agent detection technology used to treat lung disease

A new technique based on the same technology used to detect chemical warfare agents and explosives is being employed by scientists at The University of Manchester to treat hospital patients with lung disease.

From The University of Manchester 23 Jan 2006

Experts demand more funds to stop the spread of bird flu

At a meeting in Beijing to whip up funds for the global fight against bird flu, the European Union has raised its contribution to the fund by $20 million taking their total commitment to $120 million, but other contributions appear to be thin on the ground.

18 Jan 2006

Anti-Obesity diet drug from cannabis works!

For those whose New Year's resolution was to yet again try to lose those extra kilos help may be at hand in the form of a new wonder drug derived from cannabis.

17 Jan 2006